Mediclinic International
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Mediclinic International generated cash of $554,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$149,000,000 last year. Net change in cash is therefore $240,000,000.
Cash Flow
| 2013 | 253.11M | -38.24M | -202.19M |
|---|---|---|---|
| 2014 | 261.45M | -143.84M | -90.92M |
| 2015 | 334.07M | -255.44M | -20.07M |
| 2016 | 320M | -1.54B | 1.24B |
| 2017 | 394M | -218M | -169M |
| 2018 | 345M | -319M | -108M |
| 2019 | 344M | -298M | -34M |
| 2020 | 456M | -182M | -207M |
| 2021 | 235M | -137M | -130M |
| 2022 | 554M | -189M | -149M |
MDC.L Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 294M | 329M | 265M | 261M | 361M | 305M | 265M | 193.78M | 153.24M | 141.08M |
Operating activities | ||||||||||
Net income | 211M | 104M | -275M | -137M | -479M | 307M | 245M | 0 | 0 | 0 |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 228M | 217M | 217M | 168M | 168M | 145M | 93M | 0 | 0 | 0 |
Stock-based compensation expense | 4M | 0 | 1M | -1M | 1M | 1M | 10M | 0 | 0 | 0 |
| Deferred income tax benefit | 4M | 0 | 1M | -1M | 1M | 1M | 10M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 15M | -10M | -15M | 4M | -3M | -4M | -1M | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 554M | 235M | 456M | 344M | 345M | 394M | 320M | 334.07M | 261.45M | 253.11M |
Investing activities | ||||||||||
Purchases Of Investments | -12M | -4M | -2M | -240M | -254M | -16M | -186M | -190.66M | 149.67M | -46.79M |
Investments In Property Plant And Equipment | -179M | 0 | -102M | -154M | -142M | -140M | -114M | -123.10M | -95.40M | -88.95M |
Acquisitions Net | -7M | 1M | -4M | -67M | -83M | 43M | -993M | -77.90M | -113.30K | 149.91M |
Cash generated by investing activities | -189M | -137M | -182M | -298M | -319M | -218M | -1.54B | -255.44M | -143.84M | -38.24M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 1.09B | 176.99M | 396.57K | 360.94M |
Payments for dividends | 0 | 0 | -59M | -59M | -58M | -62M | -48M | -45.70M | -38.97M | -34.75M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -3M | -1.22M | 7.02M | -1.13M |
Repayments of term debt | 0 | -196M | -101M | 0 | -30M | 0 | -85M | 0 | -60.84M | -1.77B |
Cash used in financing activities | -149M | -130M | -207M | -34M | -108M | -169M | 1.24B | -20.07M | -90.92M | -202.19M |
Net Change In Cash | 240M | -35M | 64M | 4M | -100M | 56M | 40M | 71.95M | 44.18M | 51.20M |
Cash at end of period | 534M | 294M | 329M | 265M | 261M | 361M | 305M | 265.73M | 197.43M | 192.29M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |